PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pneumonia vaccine trial aims to shield 3,000 kids from deadly infection
⭐️ VACCINE ⭐️ Recruiting nowThis Phase 3 trial is testing a new 13-valent pneumococcal conjugate vaccine (PCV13) in over 3,000 healthy infants and children aged 6 weeks to 5 years. The goal is to see if the vaccine is safe and triggers a strong immune response compared to an existing vaccine. If it works, i…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New vaccine aims to shield toddlers from 24 pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (PCV24) designed to protect children aged 2 to 23 months against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. Around 180 healthy children will receive either the new vaccine or an existing one …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New 24-Strain pneumonia vaccine trial launches for kids
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (RZ700) designed to protect infants and young children against 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. About 480 healthy children aged 6 weeks to 71 months will receive the vaccine to see if it t…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
New 24-Valent vaccine aims to shield children from more pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called PCV24 in 420 healthy children aged 2 months to 5 years. The vaccine targets 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. Researchers will compare it to an existing vaccine to see if it is safe …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC